Ferritin Quantitative Test

SARS-CoV-2 Antigen Rapid Qualitative Test Type B

Product Detail

Application


The SARS-CoV-2 Antigen Rapid Qualitative Test is intended for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in human nasal swabs samples from individuals who are suspected of COVID-19. The test is intended as an aid in diagnosis of symptomatic individuals within the first 7 days of symptom onset.


Product Features


Fast Result
Easy-to-use
High specificity and sensitivity
Room temperature storage


Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
Biotime HCY Rapid Quantitative Test
HCY Rapid Quantitative Test
Homocysteine, often shortened to HCY, is a thiol containing amino acid produced by the intracellular demethylation of methionine. Excess HCY in the bloodstream may cause injuries to arterial vessels due to its irritant nature and result in inflammation and plaque formation, which may eventually cause a blockage of blood flow to the heart.
biotime HBsAg Rapid Quantitative Test
HBsAg Rapid Quantitative Test
HBsAg is the surface antigen of the hepatitis B virus (HBV). It indicates current hepatitis B infection. Biotime HBsAg Rapid Quantitative Test kit can detect the specimen of serum and plasma.
biotime HCV Rapid Quantitative Test
HCV Rapid Quantitative Test
Hepatitis C is a liver disease caused by the hepatitis C virus (HCV): the virus can cause both acute and chronic hepatitis, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness. Hepatitis C is a major cause of liver cancer.
Malaria P.f/Pan Antigen Rapid Qualitative Test
Malaria P.f/Pan Antigen Rapid Test
The Malaria P.f/Pan Antigen Rapid Test is a rapid lateral flow immunoassay for the qualitative detection of Histidine-Rich Protein II (HRP-II) specific to Plasmodium falciparum (P.f) and Plasmodium lactate dehydrogenase (pLDH) specific to Plasmodium species (Pan) in human whole blood specimen. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with Malaria. For professional in vitro diagnostic use only.
FIA Analyzer
FLI-100 FIA Analyzer
The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.
Neutralizing Antibody Rapid Test
SARS-CoV-2 Neutralizing Antibody Rapid Test
Biotime SARS-CoV-2 Neutralizing Antibody rapid test is a fluorescence immunoassay(FIA) for the qualitative detection of total neutralizing antibodies to SARS-CoV-2 in human serum or plasma. It is useful as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
PCT Rapid Quantitative Test (Chemiluminescence Immunoassay)
PCT Rapid Quantitative Test (Chemiluminescence Immunoassay)
PCT Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Procalcitonin concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of inflammation diseases.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact